Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
收藏官方服务：
资源简介：
Glycoprotein IIb/IIIa inhibitors represent a new promising class of antiplatelet medications. Their use in acute coronary syndromes and for patients undergoing percutaneous coronary intervention has been the subject of a number of large controlled trials using both the intravenous and the oral forms. In this review, we present a systematic overview of these trials.
提供机构：
BMC创建时间：
2001-07-26
